Risk Factors Associated With Cytomegalovirus Infection in Orthotopic Liver Transplant Patients

Transplantation Proceedings

Volumn 38, Issue 6, 2006, Pages 1922-1923

  Hoppe, L ^a   Marroni, C A ^a   Bressane, R ^a   Lago, L ^a   Schiavo, F L ^a   Cigerza, G C ^a   Brandao A B M ^a   Zanotelli, M L ^a   Cantisani, G P C ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VIRUS ANTIGEN;

ADULT; AGE; ALCOHOL LIVER CIRRHOSIS; ANTIGEN DETECTION; ARTICLE; BLOOD COMPONENT; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DONOR; FEMALE; GENDER; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REOPERATION; RISK FACTOR; SURVIVAL; VIRUS INFECTION;

CYCLOSPORINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33747056881     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.06.075     Document Type: Article

References (7)

1. Angelis M., Cooper J.T., and Freeman R.B. Impact of donor infection on outcome of orthotopic liver transplantation. Liver Transpl 9 (2003) 451
2. Jong M.D., Galasso G.J., Gazzard B., et al. Summary of II international symposium on cytomegalovirus. Antiviral Research 39 (1998) 141
3. Singh N., Wannstedt C., Keyes L., et al. Impact of evolving trends in recipients and donor characteristics on cytomegalovirus infection in liver transplant recipients. Transplantation 79 (2005) 1428
4. Rowshani A., Bemelman F., Leeuwen E.M.M., et al. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation 79 (2005) 381
5. Seehofer D., Rayes N., Tullius S.G., et al. CMV hepatitis after liver transplantation. incidence, clinical course, and long-term follow-up. Liver Transpl 8 (2002) 1138
6. Meer J.T.M., Drew W.L., Bowden R.A., et al. Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection. Antiviral Res 32 (1996) 119
7. Maes B.D., and Vanrenterghem Y.F.C. Cyclosporine. advantages versus disadvantages vis-à-vis tacrolimus. Transplant Proc 36 suppl 2S (2004) 40S